SIF

Poster Session Abstracts
P-V - Pharmacology of the Nervous System (I); Psychopharmacology


DIFFERENTIAL ROLE OF METABOTROPIC GLUTAMATE 4 (MGLU4) RECEPTOR EXPRESSED IN GLIAL CELLS
Spampinato S., Merlo S., Sinagra T., Calabrese R., Nicoletti F., Sortino M.
ACTIVATION OF THE RAGE/NF-κB AXIS MEDIATES PRONEUROGENIC EFFECT OF HMGB-1 ANDAβ-OLIGOMERS
Bortolotto V., Meneghini V., Francese M., Dellarole A., Carraro L., Terzieva S., Grilli M.
MICROGLIA UNDER SIMULATED MICROGRAVITY: A NOVEL STRATEGY FOR CHRONIC PAIN RELIEF
Boccella S., Guida F., De Chiaro M., De Gregorio D., Marabese I., Rossi F., Viviani A., Maione S., de Novellis V.
ADENOSINE IS RELEASED PER SE FROM CELL, IN PHYSIOLOGICAL CONDITION, AND IS CONTAINED IN SYNAPTIC VESICLES
Corti F., Cellai L., Melani A., Donati C., Bruni P., Pedata F.
THE CYTOTOXIC NECROTIZING FACTOR 1 (CNF1) INCREASES BRAIN ENERGY LEVEL, COUNTERACTS NEUROINFLAMMATORY MARKERS AND RESCUES COGNITIVE DEFICITS IN A MURINE MODEL OF ALZHEIMER’S DISEASE
Loizzo S., Rimondini R., Travaglione S., Fabbri A., Guidotti M., Ferri A., Campana G., Fiorentini C.
ADAM10 EXOCYTOSIS/ENDOCYTOSIS IN SPINES: LOOKING FOR NEW THERAPEUTIC STRATEGIES
Musardo S., Pelucchi S., Di Marino D., Gardoni F., Marcello E., Di Luca M.
MUSCULAR MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION IN A RODENT MODEL OF PARKINSON’S DISEASE
Bongiorno A., Verri M., Blandini F., Levandis G., Cerri S., Siani F., Pastoris O., Dossena M.
MICE EXPOSED TO CHRONIC PSYCHOSOCIAL STRESS OVEREAT PALATABLE ENERGY DENSE FOOD AND SHOW ALTERED EXPRESSION OF SELECTED NEUROPEPTIDES IN KEY BRAIN AREAS.
Tempesta B., Romano A., Coccurello R., Cianci S., Bellantuono S., Moles A., Gaetani S., Cuomo V.
DISTRIBUTION PATTERNS OF CB1 MRNA AND PROTEIN IN A TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE: A LONGITUDINAL STUDY
Lavecchia A., Bedse G., Romano A., Elphick M., Gaetani S., Cassano T., Cuomo V.
DUAL INHIBITION OF CYCLOOXYGENASE AND 5-LIPOXYGENASE BY FLAVOCOXID PROTECTS AGAINST KAINIC ACID-INDUCED BRAIN EXCITOTOXICITY
Squadrito F., Rinaldi M., Irrera N., Marini H., Pallio G., Bitto A., Altavilla D., Minutoli L.
AMYLOID PRECURSOR PROTEIN PROCESSING MODULATES FAST TAU PHOSPHORYLATION AND COMPARTIMENTALIZATION DURING MITOSIS
Passarella D., Nizzari M., Porcile C., Cocco F., Ambrosino P., Soldovieri M., Florio T., Taglialatela M., Russo C.
PROTECTIVE EFFECTS OF CAFFEIC ACID PHENETHYL ESTER AGAINST OXIDATIVE STRESS-INDUCED CYTOTOXICITY IN HUMAN NEUROBLASTOMA CELLS
Tarozzi A., Cervellati C., Morroni F., Sita G., Cantelli Forti G., Hrelia P.
EFFECTS OF CANNABINOID COMPOUNDS ON MEMORY CONSOLIDATION IN RATS
Ratano P., Savo M., Campolongo P., Cuomo V.
EFFECTS OF CLINICALLY USED SEDATIVE/ANESTHETIC DRUGS ON MEMORY FOR AVERSIVE EXPERIENCES IN RATS
Morena M., Peloso A., Palmery M., Campolongo P., Cuomo V.
RESISTANCE TO DIET-INDUCED OBESITY IS ASSOCIATED TO SELECTIVE EPIGENETIC REGULATION OF HYPOTHALAMIC NEUROPEPTIDES GENE EXPRESSION
Micioni Di Bonaventura M., Pucci M., Maccarrone M., Cuomo V., Ciccocioppo R., Gaetani S., Cifani C., D'Addario C.
ANTIEPILEPTIC EFFECT OF AMP BY DIRECT ACTIVATION OF ADENOSINE A1 RECEPTOR
Muzzi M., Coppi E., Pugliese A., Chiarugi A.
COMBINATION OF PEA (PALMITOYLETHANOLAMIDE) WITH LUTEOLIN PROMOTES A SYNERGISTIC NEUROPROTECTION AND MAST CELLS MODULATION IN CELL-BASED MODELS OF BRAIN ISCHEMIA.
Parrella E., Porrini V., Iorio R., Piva R., Benarese M., Fusco M., Spano P., Pizzi M.
TARGETED ACETYLATION OF NF-KAPPAB AND HISTONES BY EPIGENETIC DRUGS REDUCES POST-ISCHEMIC BRAIN INJURY IN MICE WITH AN EXTENDED THERAPEUTIC WINDOW
Lanzillotta A., Pignataro G., Branca C., Cuomo O., Sarnico I., Benarese M., Annunziato L., Spano P., Pizzi M.
CHF5074, IN CLINICAL DEVELOPMENT FOR THE TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE, ACTS AS A MICROGLIAL MODULATOR SWITCHING MICROGLIA FROM M1 TO M2 ACTIVATION STATE
Porrini V., Branca C., Lanzillotta A., Benarese M., Imbimbo B., Pizzi M.
EARLY MATERNAL SEPARATION ATTENUATES THE EFFECT OF SOCIAL ISOLATION DURING ADOLESCENCE ON HPA AXIS RESPONSIVENESS IN ADULT RATS
Biggio F., Pisu ., Locci V., Garau A., Boero G., Utzeri C., Olla P., Mostallino M., Serra M.
THE SELECTIVE ADENOSINE A2A RECEPTOR AGONIST CGS21680 IS NEUROPROTECTIVE IN A RAT MODEL OF FOCAL CEREBRAL ISCHEMIA
Cellai L., Melani A., Corti F., Vannucchi M., Pedata F.
TIME-DEPENDENT EFFECTS OF ANTIDEPRESSANT TREATMENTS ON MIRNOME EXPRESSION PROFILE IN HIPPOCAMPUS OF RATS
Seguini M., Tardito D., Mallei A., Merelli I., Corrada D., Milanesi L., Racagni G., Popoli M.
ENHANCEMENT OF DOPAMINE RELEASE INDUCED BY NEW CLASS OF NITRIC OXIDE DONOR DERIVED FROM PILOTY ACID: AN IN VITRO MICRODIALYSIS STUDY
Pirisinu M., Farina D., Secchi O., Biosa A., Garribba E., Porcheddu A., Sanna D., Serra P., Desole M., Migheli R.
DEVELOPMENT OF NEX MICROFLUIDIC-AMPEROMETRIC DEVICE FOR MONITORING DOPAMINE SECRETION FROM PC12 CELLS SUSPENSION USING A NANOSTRUCTURED MICROSENSOR
Zinellu M., Bazzu G., Biosa A., Spano G., Spissu Y., Calia G., Bacciu A., Serra P.
α-SYNUCLEIN ANTIAGGREGATING PROPERTIES AND CYTOPROTECTIVE EFFECTS OF CURCUMIN AND CURCUMIN-DERIVATIVES
Serra P., Dedola S., Marchiani A., Mammi S., Siligardi G., Hussain R., Tessari I., Bubacco L., Delogu G., Fabbri D., Dettori M., Sanna D., Ruzza P.
DEVELOPMENT AND CHARACTERISATION OF A TYROSINASE-BASED BIOSENSOR FOR THE IN VITRO-STUDY OF A NEW CLASS OF NATURAL-LIKE TYROSINASE INHIBITORS
Rocchitta G., Cossu S., Pirisinu M., Migheli R., Delogu G., Dettori M., Fabbri D., Serra P.
BLUNTING OF CB1-MEDIATED EFFECTS IN THE STRIATUM OF RATS OVEREXPRESSING ADENOSINE A2A RECEPTORS
Potenza R., Chiodi V., Beggiato S., Ferrante A., Armida M., Pèzzola A., Matteucci A., Ferraro L., Domenici M., Popoli P.
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-ALPHA ACTIVATION PRODUCES ANTIDEPRESSANT-LIKE EFFECTS IN MICE
Cristiano C., D'Agostino G., Avagliano C., De Caro C., Orefice N., La Rana G., Russo R., Reggiani A., Piomelli D., Calignano A.
ETHANOL REDUCES HYPERPOLARIZATION-ACTIVATED CATION CURRENTS (IH) RECORDED IN HIPPOCAMPAL CA3 PYRAMIDAL NEURONS: IMPLICATION ON THE INHIBITORY ACTION ON NEURONAL EXCITABILITY
Licheri V., Talani G., Saderi D., Masala N., Trudu F., Lai M., Biggio G., Sanna E.
FATTY ACID ACYL ETHANOLAMINES AND PPAR-ALPHA IN NEURODEGENERATIVE AND NEUROLOGICAL DISEASES. CELLULAR MODELS OF NEURODEGENERATION: PRELIMINARY DATA
Avagliano C., Cristiano C., Orefice N., De Caro C., D'Agostino G., La Rana G., Russo R., Calignano A.
SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 2‑(ACYLAMINO) THIOPHENE DERIVATIVES AS METABOLICALLY STABLE, ORALLY EFFECTIVE, POSITIVE ALLOSTERIC MODULATORS OF THE GABAB RECEPTOR
Porcu A., Casti A., Madeddu C., Maccioni P., Pedani V., Castelli M.
EPIGENETIC MODIFICATIONS ASSOCIATED WITH SELECTIVE NEURONAL VULNERABILITY IN A RAT MODEL OF TRANSIENT GLOBAL BRAIN ISCHEMIA
Motolese M., Mastroiacovo F., Cannella M., Gaglione A., Battaglia G., Bruno V., Nicoletti F.
DISTINCT EFFECTS OF ANTIDEPRESSANT TREATMENT ON ANHEDONIA AND INFLAMMATION IN STRESSED RATS
Macchi F., Molteni R., Racagni G., Papp M., Riva M.
PRAMIPEXOLE DISRUPTS SYNAPTIC PLASTICITY IN THE CA1 AREA OF THE HIPPOCAMPUS OF RATS THAT DEVELOP CONTRAFREELOADING FOR WATER, AN ANIMAL MODEL OF COMPULSIVE BEHAVIOR
Schepisi C., Piccinin S., Doronzio S., Pignataro A., Feligioni M., Ferraina C., Ammassari-Teule M., Nisticò R., Nencini P.
BEHAVIORAL AND MORPHOLOGICAL CHANGES IN A RODENT DEVELOPMENTAL DISRUPTION MODEL OF SCHIZOPHRENIA
Micale V., Kucerova J., Drazanova E., Korinek R., Starcuk Jr Z., Sulcova A.
INVOLVEMENT OF PATIENTS AND THEIR FAMILIES IN TREATMENT CHOICES IN A PSYCHIATRIC SETTING
Girardi A., Piccinni C., Montardi G., Gallingani F., Tarricone I., Romagnoli G., Donegani I., Berardi D., Fioritti A., Poluzzi E., De Ponti F.
SERUM METABOLIC SIGNATURE IN AN ANIMAL MODEL OF BINGE EATING BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
Alboni S., Micioni Di Bonaventura M., Righi V., Schenetti L., Brunello N., Cifani C.
REGULATION OF NOCICEPTIN/ORPHANIN FQ SYSTEM GENE EXPRESSION IN BINGE EATING EPISODES
Pucci M., Micioni Di Bonaventura M., Maccarrone M., Cuomo V., Ciccocioppo R., Gaetani S., D'Addario C., Cifani C.
CALORIC RESTRICTION INCREASES THE SENSITIVITY TO THE HYPERPHAGIC EFFECT OF NOCICEPTIN/ORPHANIN FQ LIMITING ITS ABILITY TO REDUCE BINGE EATING IN FEMALE RATS
Micioni Di Bonaventura M., Ubaldi M., Massi M., Ciccocioppo R., Cifani C.
ACUTE ADMINISTRATION OF PALMITOYLETHANOLAMIDE: BEHAVIOURAL STUDIES
Mameli A., Scherma M., Cadeddu F., Collu R., Fattore L., Fratta W., Fadda P.
INCREASED CANNABINOID INTRAVENOUS SELF-ADMINISTRATION IN THE OLFACTORY BULBECTOMY RAT MODEL OF DEPRESSION
Giugliano V., Amchova P., Zanda M., Antinori S., Kucerova J., Sulkova A., Fadda P., Fratta W., Fattore L.
PREGNENOLONE SULPHATE IMPROVES MEMORY PROCESSING IN EARLY-HANDLED FEMALE RATS
Brancato A., Marino R., Sardo P., Cannizzaro E., Plescia F., Cannizzaro C.
EVALUATION OF BEHAVIORAL PHENOTYPES IN RATS SHOWING BINGE EATING BEHAVIOR
Satta V., Scherma M., Fattore L., Fratta W., Fadda P.
BEHAVIORAL VALIDATION OF A NOVEL ANIMAL MODEL THAT CAPTURE BOTH THE EMOTIONAL AND COGNITIVE FEATURES OF POST-TRAUMATIC STRESS DISORDER
Berardi A., Coseglia M., Trezza V., Campolongo P., Cuomo V.
PLASMA CONCENTRATIONS OF RISPERIDONE IN CHILDREN, ADOLESCENTS AND ADULTS WITH PSYCHIATRIC DISORDERS
Italiano D., Santoro V., D'Arrigo C., Gagliano A., Germano' E., Siracusano R., Bruno A., Spina E.
ANTIDEPRESSANT-LIKE PROPERTIES OF THE DUAL FAAH/TRPV1 BLOCKERN-ARACHIDONOYLSEROTONIN: ROLE OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
Navarria A., Tamburella A., Iannotti F., Camillieri G., Gozzo L., Verde R., Micale V., Imperatore R., Leggio G., Drago F., Di Marzo V.
PSYCHOLOGICAL ASSESSMENT IN PATHOLOGICAL GAMBLERS TREATED WITH ESCITALOPRAM
Picone F., Maniaci G., Dimarco T., Brancato A., Plescia F., Cannizzaro C.
LEVELS OF XANTHURENIC ACID, A PUTATIVE ACTIVATOR OF TYPE 2/3 METABOTROPIC GLUTAMATE RECEPTORS, ARE REDUCED IN THE BLOOD OF SCHIZOPHRENIC PATIENTS AND THEIR HEALTHY RELATIVES
Fazio F., Curto M., Lionetto L., Napoletano F., Vignaroli G., Capi M., Corigliano V., Comparelli A., Iacovelli L., Molinaro G., Bruno V., Battaglia G., Simmaco M., Nicoletti F.